Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-001633
Filing Date
2022-02-22
Accepted
2022-02-22 17:00:21
Documents
1
Period of Report
2022-02-18

Document Format Files

Seq Description Document Type Size
1 form4-02222022_050202.html 4  
1 form4-02222022_050202.xml 4 4108
  Complete submission text file 0001415889-22-001633.txt   5486
Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Issuer) CIK: 0001821323 (see all company filings)

EIN.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SIGILON THERAPEUTICS, INC. 100 BINNEY STREET, SUITE 600 CAMBRIDGE MA 02142
Business Address
Orfali May (Reporting) CIK: 0001894283 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39746 | Film No.: 22659128